Key result
The HLA-DR3 antigen was associated with a decreased risk of idiopathic dilated cardiomyopathy compared with controls.
Why the study?
Does the presence of the HLA-DR3 antigen reduce the risk of idiopathic dilated cardiomyopathy?
Meta-Analysis (n=11,761)
Does the presence of the HLA-DR3 antigen reduce the risk of idiopathic dilated cardiomyopathy?
The presence of the HLA-DR3 antigen is associated with a significantly decreased risk of idiopathic dilated cardiomyopathy, suggesting a protective genetic effect.
Answers are grounded in this paper and cite their sources.
HLA-DR3 may mark lower IDC susceptibility for risk assessment; extends genetic association data for cardiomyopathy research.
Idiopathic dilated cardiomyopathy (IDC) has been hypothesized as a multifactorial disorder initiated by an environment trigger in individuals with predisposing human leukocyte antigen (HLA) alleles. Published data on the association between HLA-DR3 antigen and IDC risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Studies were identified by searching the PUBMED and Embase database (starting from June 2015). A total of 19 case-control studies including 1378 cases and 10383 controls provided data on the association between HLA-DR3 antigen and genetic susceptibility to IDC. Overall, significantly decreased frequency of HLA-DR3 allele (OR=0.72; 95%CI=0.58-0.90; P=0.004) was found in patients with IDC compared with controls. When stratified by myocardial biopsy or non-biopsy cases, statistically decreased risk was found for IDC in myocardial biopsy cases (OR=0.69; 95%CI=0.57-0.84; P=0.0003). In the subgroup analysis by ethnicity, borderline statistically significantly decreased risk was found among Europeans from 12 case-control studies (OR=0.76; 95%CI=0.58-1.00; P=0.05). In conclusion, our results suggest that individuals with HLA-DR3 antigen may have a protective effect against IDC.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2016) conducted a meta-analysis in Idiopathic dilated cardiomyopathy (n=11,761). HLA-DR3 antigen vs. Controls was evaluated on Idiopathic dilated cardiomyopathy risk (OR 0.72, 95% CI 0.58-0.90, p=0.004). The HLA-DR3 antigen was associated with a decreased risk of idiopathic dilated cardiomyopathy compared with controls.
Synapse has enriched 10 related papers. Consider them for comparative context: